Share this video  

EAU 2020 | ProPSMA: PSMA-PET/CT imaging for high risk prostate cancer

Michael Hofman, MBBS, FRACP, FAANMS, of the Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the results of the ProPSMA study, a prospective, randomized, multi-center trial of PSMA-PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).